Skip to main content

Table 3 Freezing associated factors

From: Profile of idiopathic parkinson’s disease in Moroccan patients

Independant variables n (%) Univariate analysis Multivariate analysis
OR CI 95% p OR CI 95% p
Age of onset        
  > 65 years 4 (14,3) 1      
  < 45 years 5 (33,3) 3 0,66- 13,5 0,15    
   45-54 years 5 (17,9) 1,3 0,31- 5,4 0,71    
   55- 65 years 6 (14,3) 1 0,25- 3,9 1,00    
Gender - 0,35 0,10- 1,10 0,078    
Disease duration* 5 [3;9] 1,1 1,03- 1,26 0,009 1 0,99-1,01 0,07
Dysautonomic troubles 13 (26,0) 1,5 0,78- 2,90 0,22    
Cognitive troubles 4 (30,8) 2,3 0,65- 8,70 0,18    
L-dopa treatment duration* 5 [3;9] 1,01 1,003- 1,02 0,008 1 1,1-11,8 0,06
LED (mg) ** 667 ± 446 1,001 1,000- 1,002 0,02    
  ≤ 600 mg 5 (7,8) 1      
  > 600 mg 15(32,6) 0,17 0,05- 0,50 0,002 4.8 1,56-14,9 0,006
Treatment        
   Dopaminergic agonists 0 1      
   Levodopa 9 (22,0) 0,92 0,33- 2,50 0,87    
   DA + levodopa 11 (23,4) 0   0,71    
  1. *median and quartiles ;**mean and standard deviation; OR: odds-ratio; CI: confidence interval; LED: levodopa equivalent dose.